Scrip is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViroMed Co. Ltd.

www.viromed.co.kr

Latest From ViroMed Co. Ltd.

Korea Eases Stock Rules To Help Bioventures Stay Listed, Focus On R&D

South Korea continues to ease stock market listing rules to help bioventures and other innovative companies sustain growth and focus on their core R&D activities. 

South Korea Financing

Finance Watch: Third Rock Raises $770m To Launch Up To 12 New Companies

The VC firm known for its new company formation efforts will launch 10-12 biopharma, device and diagnostic ventures with its fifth fund. Also, EpimAb raises a $74m series B round, three more drug developers join the IPO queue and Amicus leads recent follow-on offerings.

Financing StartUps and SMEs

Interview: ViroMed On Pricing, Manufacturing World’s First Broadly Used Gene Therapy

The head of global business strategy at ViroMed, one of the gene therapy companies nearing the commercial stage in the US, talks exclusively to Scrip about the South Korean biotech’s strategies, including for pricing and manufacturing, which are emerging as key considerations for developers.

South Korea Pricing Strategies

Asia Executives On The Move: Comings And Goings At BeiGene, Harbour BioMed, TLC, GC Pharma

New Year brings a flurry of new executive moves in the life sciences sector in Asia Pacific, including the departure of BeiGene's chief commercial officer and a new chief strategy officer and CMO at Harbour Biomed.

Appointments Asia Pacific
See All

Company Information

  • Industry
  • Biotechnology
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Pharmaceuticals
    • Drug Delivery
  • Therapeutic Areas
  • Cancer
  • Cardiovascular
  • Musculoskeletal & Connective Tissue Disorders
  • Neurology, Nervous System
  • Alias(es)
  • ViroMed Ltd.
  • VM BioPharma
  • Ownership
  • Public
  • Headquarters
  • Worldwide
    • Asia
      • Pacific Rim
        • South Korea
  • Parent & Subsidiaries
  • ViroMed Co. Ltd.
  • Senior Management
  • Yongsoo Kim, PhD, Pres. & CEO
    Sungchul Kim, CFO
    Sunyoung Kim, CSO
  • Contact Info
  • ViroMed Co. Ltd.
    Phone: (82)
    5th Floor, Bldg. 203, Seoul Nat'l Univ.
    599 Gwanak-ro
    Seoul, 151-747
    South Korea
Advertisement
Advertisement
UsernamePublicRestriction

Register